Skip to main content

CDT Equity Inc.

CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001896212

In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.

Other share classesCDTTW

Q2 2024 vs. Q1 2024

How the institutions holding CDT Equity Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CDT: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders1829+11
Shares1.61M2.93M+1.31M (+81.6%)
Value$5.91M$3.12M−$2.80M (−47.3%)

New holders (14)

Institutions that held CDT Equity Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CDT in Q2 2024
InstitutionSharesValue% of portfolio
New York State Common Retirement Fund98,100$104.0K0.00%
Charles Schwab Investment Management Inc53,111$56.3K0.00%
Invesco Ltd.48,143$51.0K0.00%
Bridgeway Capital Management, LLC45,000$47.7K0.00%
Renaissance Technologies LLC26,000$27.6K0.00%
Rhumbline Advisers23,899$25.3K0.00%
Alpine Global Management, LLC21,592$22.9K0.00%
Corebridge Financial, Inc.12,399$13.3K0.00%
Virtu Financial LLC12,629$13.0K0.00%
Citigroup Inc5,411$5.74K0.00%
Ameritas Investment Partners, Inc.2,258$2.39K0.00%
Royal Bank of Canada2,168$2.00K0.00%
California State Teachers Retirement System1,670$1.77K0.00%
Amalgamated Bank797$1.00K0.00%

Sold out (3)

Institutions that held CDT Equity Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CDT in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Qube Research & Technologies Ltd40,985$150.4K
Y-Intercept (Hong Kong) Ltd19,272$70.7K
Macquarie Group Ltd195$1